LSI America Corp
| About us | The Company finally succeeded in acquiring control of LifeScience Corporation and its IP rights for Ondrox, for a price in the seven digits range in 1995 from the University of Texas, M. D. Anderson Cancer Center based in Houston, Texas, which remains a 10% shareholder in LifeScience Corporation. Research on the product was done in the laboratories of M. D. Anderson Cancer Center, which is rated No.1 by U. S. News& World Report. In 2002, the U. S. Patent Office granted the patent which in its Abstract claims that it is protective against cancer and cardio vascular disease, as well as helps improve immunity and increase longevity. Based on tests performed on animals. It is also the only antioxidant formulation that is endorsed by the National Foundation for Cancer Research, Washington, D. C. The Company outsources all of its operational functions to third parties. These include manufacturing, distribution, call center, fulfillment services and accounting. Ondrox was also sold under private labels by other companies including The Sharper Image. Sales are also conducted by partners in Korea and China. The principal of LSI America Corporation, David K. G. Chan, is a well known business man who is also Chairman Emeritus of the Texas Asian Chamber of Commerce, as well as CEO of many corporations. These include a company in Africa that was used by Harvard Business School as a case study(Ejura Farms Ghana Ltd. ) and another that was named "Manufacturer of the Year 1992" located in Austin(Austin Concstuction Steel). He is also Chairman of Advisory Board of Jtec, Inc. A California company engaged in enterprise management software application, and is used to manage the construction projects of Olympic 2008 in China. LSI America Corporation is indirectly owned by the Asia Development Trust, based in Anguilla. The beneficiary of the Trust is David K. G. Chan's family. Sister companies of the Trust are engaged in deal making and project development in several countries in Asia, including Nepal and China. |
|---|---|
| Industry Focus | Drugs & Medications, Enzyme (Ferment) Preparations, Health Product Agents, Herbs & Natural Remedies |
| Business Type | Manufacturer |
| Products/Services | Patented antioxidant formulation developed by n0.1 cancer center in the u. S. Designed to protect against cancer, improve immunity and protect against cardio-vascular diseases and increase longevity |
| Our Markets | North America |
| No. of Employees | Less than 5 People |
| Annual Sales Range(USD) | Below US$1 Million |
| Year Established | 1994 |
| Legal Representative(CEO) | David Chan |
| Certificates | FDA Certificate of Free Sale |
